Skip to content

Wearable external loop recorder for continuous cardiac monitoring

A pilot prospective study to evaluate Electrocardiogram (ECG) signal acquisition and functionality of newly developed External Cardiac Monitoring (ECM) prototype

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023576
Enrollment
40
Registered
2020-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I499- Cardiac arrhythmia, unspecified

Interventions

None listed

Sponsors

India Medtronic Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Above 18 years of age 2) Patients with the previous history of cardiovascular disease 3) Patients with a previous history of cardiovascular disease (or) suspected (or) increased risk of cardiac arrhythmia in the setting of unexplained syncope, cryptogenic stroke or with transient symptoms of dizziness, palpitations, or chest pain 4) Enroll only In-patients who can complete for the Group A study 5) The subject is willing to sign the Informed consent form

Exclusion criteria

Exclusion criteria: 1) Patients implanted with Cardiac Implantable Electronic Device (CIED) (e.g., IPG, ICD, CRT, etc.) 2) Any high-risk patient who is already implanted or needs an implant with other life sustaining equipment during the course of study, that may interfere with the function of Cardilinq External Cardiac Monitor(ECM) prototype should be excluded as per physician discretion 3) Patients with a history of sweat allergy 4) Patients with prior evidence of skin irritation or symptoms of skin infection OR wound at any point where the ZephyrTM Bioharness chest strap will contact the subject 5) Female patients who are pregnant and breastfeeding 6) Not willing to consent

Design outcomes

Primary

MeasureTime frame
The primary objective of the study to evaluate the quality of the ECG signal acquisition to assess the incidence of cardiac arrhythmia during short-term (up to 24hrs) and long-term monitoring (for 3 months), via Group A and Group B studies respectively.Timepoint: 24 hours

Secondary

MeasureTime frame
- To assess the patient comfort level and compliance with the prototype use while being continuously monitored for 3 months. - To assess the functionality of the prototype in acquiring ECG data for a period of 3 Months. Timepoint: 3 Months

Countries

India

Contacts

Public ContactVinay Rajan

India Medtronic Pvt. Ltd.

vinay.rajan@medtronic.com9619332703

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026